Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The long noncoding RNA sONE represses triple‐negative breast cancer aggressiveness through inducing the expression of miR‐34a, miR‐15a, miR‐16, and let‐7a
R.A. Youness, Hafez M. Hafez, Emad Khallaf, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 11, pp. 20286-20297
Closed Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Recent Advances in Tannic Acid (Gallotannin) Anticancer Activities and Drug Delivery Systems for Efficacy Improvement; A Comprehensive Review
R.A. Youness, Rabab Kamel, Nermeen A. Elkasabgy, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1486-1486
Open Access | Times Cited: 110
Decoding hepatocarcinogenesis from a noncoding RNAs perspective
Mostafa K. Abd El‐Aziz, Alyaa Dawoud, Caroline Joseph Kiriacos, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 9, pp. 1982-2009
Closed Access | Times Cited: 56
Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy
Tasneem Abaza, Mostafa K. Abd El‐Aziz, Kerolos Ashraf Daniel, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16484-16484
Open Access | Times Cited: 49
Roles of miRNA and IncRNA in triple-negative breast cancer
Juan Xu, Kangjing Wu, Qiaojun Jia, et al.
Journal of Zhejiang University SCIENCE B (2020) Vol. 21, Iss. 9, pp. 673-689
Open Access | Times Cited: 99
lncRNA PVT1 Promotes Tumorigenesis of Colorectal Cancer by Stabilizing miR-16-5p and Interacting with the VEGFA/VEGFR1/AKT Axis
Hailu Wu, Ming Wei, Xinglu Jiang, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 20, pp. 438-450
Open Access | Times Cited: 82
lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment
Xin Jin, Wei Du, Wentao Huang, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 613-637
Open Access | Times Cited: 81
Targeting hydrogen sulphide signaling in breast cancer
R.A. Youness, Ahmed Z. Gad, Khaled Sanber, et al.
Journal of Advanced Research (2020) Vol. 27, pp. 177-190
Open Access | Times Cited: 73
MALAT-1/p53/miR-155/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer
Mustafa Abdel-Latif, Ahmed Riad, R.A. Soliman, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 4, pp. 1281-1293
Open Access | Times Cited: 46
MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer
Radwa Y. Mekky, Mai F. Ragab, Tamer Manie, et al.
Translational Oncology (2023) Vol. 31, pp. 101653-101653
Open Access | Times Cited: 35
Let-7a/cMyc/CCAT1/miR-17–5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1
Noha A. Selem, Heba Nafae, Tamer Manie, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154579-154579
Closed Access | Times Cited: 26
Puzzling out the role of MIAT LncRNA in hepatocellular carcinoma
Rawan Amr Elmasri, Alaa A. Rashwan, Sarah Hany Gaber, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 547-559
Open Access | Times Cited: 11
A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma
R.A. Assal, Noha Mousaad Elemam, Radwa Y. Mekky, et al.
Translational Oncology (2024) Vol. 45, pp. 101961-101961
Open Access | Times Cited: 11
MIAT LncRNA: A multifunctional key player in non-oncological pathological conditions
Yousra Zeinelabdeen, Tasneem Abaza, Montaser Bellah Yasser, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 447-462
Open Access | Times Cited: 9
The long non‐coding RNA landscape in triple‐negative breast cancer
Wenwen Zhang, Xiaoxiang Guan, Jinhai Tang
Cell Proliferation (2020) Vol. 54, Iss. 2
Open Access | Times Cited: 67
Systematic characterization of non‐coding RNAs in triple‐negative breast cancer
Jie Mei, Leiyu Hao, Huiyu Wang, et al.
Cell Proliferation (2020) Vol. 53, Iss. 5
Open Access | Times Cited: 52
LncRNA HEIH/miR‐939‐5p interplay modulates triple‐negative breast cancer progression through NOS2‐induced nitric oxide production
Heba Nafea, R.A. Youness, Khaled Abou‐Aisha, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 7, pp. 5362-5372
Closed Access | Times Cited: 51
Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis
Krishan Kumar Thakur, Aviral Kumar, Kishore Banik, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 12, pp. 7938-7965
Closed Access | Times Cited: 50
Competitive Endogenous Role of the LINC00511/miR-185-3p Axis and miR-301a-3p From Liquid Biopsy as Molecular Markers for Breast Cancer Diagnosis
Marwa M. Mahmoud, Eman F. Sanad, Reham A.A. Elshimy, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 50
Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19/iNOS/PD-L1 axis
Aya Soliman, R.A. Youness, Aya Sebak, et al.
Photodiagnosis and Photodynamic Therapy (2023) Vol. 44, pp. 103792-103792
Closed Access | Times Cited: 18
Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology
Noha Mousaad Elemam, Radwa Y. Mekky, Gowhar Rashid, et al.
Expert Reviews in Molecular Medicine (2024) Vol. 26
Open Access | Times Cited: 8
Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies
Hannah Hisham Rashwan, Ayman Taher, H. A. Hassan, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155223-155223
Closed Access | Times Cited: 7
Why natural killer cells in triple negative breast cancer?
Mustafa Abdel-Latif, R.A. Youness
World Journal of Clinical Oncology (2020) Vol. 11, Iss. 7, pp. 464-476
Open Access | Times Cited: 49
Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases
Huikang Xu, Lijun Chen, Sining Zhou, et al.
World Journal of Stem Cells (2020) Vol. 12, Iss. 11, pp. 1276-1294
Open Access | Times Cited: 43
Advances in natural killer cell therapies for breast cancer
Seyedeh Zahra Fotook Kiaei, Alireza Nouralishahi, Mohammad Ghasemirad, et al.
Immunology and Cell Biology (2023) Vol. 101, Iss. 8, pp. 705-726
Open Access | Times Cited: 15
Dual targeting of H2S synthesizing enzymes; cystathionine β-synthase and cystathionine γ-lyase by miR-939-5p effectively curbs triple negative breast cancer
Heba Nafea, R.A. Youness, Alyaa Dawoud, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e21063-e21063
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top